References

Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature

10.1227/01.neu.0000159714.28232.c4 · 2005 · External reference

Beneficial effects of bilateral subthalamic stimulation on non‐motor symptoms in Parkinson's disease

10.1016/j.brs.2015.08.005 · 2016 · External reference

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study

10.1016/s1474-4422(08)70114-5 · 2008 · External reference

Are patients with GBA‐Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort

2024 · External reference

Association of Subthalamic Deep Brain Stimulation with Motor, functional, and pharmacologic outcomes in patients with monogenic Parkinson disease: A systematic review and meta‐analysis

10.1001/jamanetworkopen.2018.7800 · 2019 · External reference

Motor and non‐motor outcomes of deep brain stimulation across the genetic panorama of Parkinson's disease: A multi‐scale meta‐analysis

10.1002/mdc3.13994 · 2024 · External reference

Parkinson disease and subthalamic nucleus deep brain stimulation: cognitive effects in GBA mutation carriers

10.1002/ana.26302 · 2022 · External reference

Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course

10.1002/mds.24045 · 2012 · External reference

GBA‐associated PD presents with nonmotor characteristics

10.1212/wnl.0b013e318225ab77 · 2011 · External reference

Long‐term motor and cognitive outcome of deep brain stimulation in patients with Parkinson disease with a GBA1 pathogenic variant

10.1212/wnl.0000000000214036 · 2025 · External reference

Clinical and biological determinants of longitudinal cognitive function in patients with GBA1 variants and subthalamic deep brain stimulation

10.1002/ana.78139 · 2026 · External reference

Neurostimulation for Parkinson's disease with early motor complications

10.1056/nejmoa1205158 · 2013 · External reference

Pre‐dopa deep brain stimulation: is early deep brain stimulation able to modify the natural course of Parkinson's disease?

10.3389/fnins.2020.00492 · 2020 · External reference

Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: a decision analysis

10.1002/mds.23111 · 2010 · External reference

Earlier versus later subthalamic deep brain stimulation in Parkinson's disease

10.1016/j.parkreldis.2015.06.001 · 2015 · External reference

Features of GBA‐associated Parkinson's disease at presentation in the UK tracking Parkinson's study

10.1136/jnnp-2017-317348 · 2018 · External reference

Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations

10.1001/jamaneurol.2013.1274 · 2013 · External reference

Simplified conversion method for unified Parkinson's disease rating scale motor examinations

10.1002/mds.26435 · 2015 · External reference

Conversion between mini‐mental state examination, montreal cognitive assessment, and dementia rating scale‐2 scores in Parkinson's disease

10.1002/mds.26062 · 2014 · External reference

Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT‐PD)

10.1002/1531-8257(199907)14:4<572::aid-mds1005>3.0.co;2-c · 1999 · External reference

Eleven‐year outcomes of deep brain stimulation in early‐stage Parkinson disease

10.1016/j.neurom.2022.10.051 · 2023 · External reference

Deep brain stimulation in early‐stage Parkinson disease: five‐year outcomes

10.1212/wnl.0000000000009946 · 2020 · External reference

Severe GBA1 variants drive the GBA1‐PD clinical phenotype: implications for counselling and clinical trials. Npj park

2025 · External reference

Cognitive effects of subthalamic nucleus deep brain stimulation in Parkinson's disease with GBA1 pathogenic variants

10.1002/mds.29647 · 2023 · External reference